NARI Stock Price, Chart, Stats & News

NARI chart
Fundamentals
Gross margin | 88.03% |
Operating margin | -2.84% |
Pretax margin | 0.86% |
Net margin | -0.33% |
Effective tax rate | 138.53% |
ROA | -0.24% |
ROE | -0.37% |
D/E | 0.07x |
Interest coverage ratio | -71.59x |
NARI valuation
P/E | – |
P/S | 9.49x |
P/B | 9.77x |
P/CF | 126.37x |
P/FCF | 157.55x |
P/OCF | 126.37x |
PEG | 73.50x |
EV multiple | 308.81x |
About
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment.
Similar securities
Based on sector and market capitalization











